PI
INSY

Putnam Investments’s Insys Therapeutics, Inc. INSY Stock Holding History

Putnam Investments’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,354
Closed -$240K – 1318
2016
Q3 		$240K Sell
20,354
-27,291
-57% -$415K ﹤0.01% 1217
2016
Q2 		$616K Sell
47,645
-26,506
-36% -$386K ﹤0.01% 1172
2016
Q1 		$1.19M Buy
74,151
+1,547
+2% +$29.4K ﹤0.01% 1075
2015
Q4 		$2.08M Sell
72,604
-21,623
-23% -$599K ﹤0.01% 966
2015
Q3 		$2.68M Buy
94,227
+13,376
+17% +$492K 0.01% 909
2015
Q2 		$2.9M Sell
80,851
-22,069
-21% -$687K 0.01% 934
2015
Q1 		$2.99M Sell
102,920
-44,416
-30% -$1.17M 0.01% 928
2014
Q4 		$3.11M Sell
147,336
-3,758
-2% -$74.3K 0.01% 901
2014
Q3 		$2.93M Buy
151,094
+2,138
+1% +$33.6K 0.01% 934
2014
Q2 		$2.33M Buy
148,956
+336
+0.2% +$5.43K 0.01% 994
2014
Q1 		$3.08M Sell
148,620
-70,506
-32% -$1.4M 0.01% 939
2013
Q4 		$2.83M Sell
219,126
-153,426
-41% -$2.13M 0.01% 954
2013
Q3 		$4.34M Sell
372,552
-745,581
-67% -$6.12M 0.01% 782
2013
Q2 		$5.16M Buy
+1,118,133
New +$4.1M 0.02% 673

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments's INSY Position: Q4 2016 in Review

Putnam Investments sold out of Insys Therapeutics, Inc. (INSY) in Q4 2016, closing a stake of 20,354 shares — an estimated $240K sold.

Putnam Investments first reported a position in INSY in Q2 2013 and held it in 14 quarters. The position peaked at $5.16M in Q2 2013. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • Putnam Investments reported no remaining Insys Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Putnam Investments sold 20,354 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $240K.
  • Putnam Investments first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 14 quarters.
  • Putnam Investments's Insys Therapeutics, Inc. position peaked at $5.16M in Q2 2013.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on Putnam Investments's 13F filing for Q4 2016, filed 14 Feb 2017.